A Study to Evaluate the Pharmacokinetics and Safety of Diluted vs. Undiluted Intravenous DA-5217 in Healthy Adult Subjects

NCT07027982 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Adults

Interventions

DRUG: Diluted Intravenous DA-5217
DRUG: Undiluted Intravenous DA-5217

Sponsor

Dong-A ST Co., Ltd.